My Greatest Professional Experience Yet, Has Been Building Alpha Tau, says CEO Uzi Sofer
I have been involved in healthcare innovation since 2003, for almost 18 years, as I concluded that the field would let me leverage my...
top of page
Treating Cancer With Precision
News​
Categories
Sign up
Featured Posts
Archive
Follow Us
- Jun 4, 2020
Alpha Tau Medical Announces Successful Completion of New $26 Million Funding Round
Tel Aviv, Israel, June 4, 2020 - Alpha Tau Medical, the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, is pleased...
- Jun 3, 2020
Lela’s Story of her Cancer Treatment Journey that Brought her to Alpha DaRT
Introduction When 78-year-old Israeli cancer patient Lela Parnes stumbled upon the Alpha DaRT treatment in 2017, with information from a...
- Apr 7, 2020
Alpha Tau Medical Announces Exclusive Distribution Arrangement with Medison Canada For Breakthrough
Tel Aviv, Israel -- Alpha Tau Medical – the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, and Medison Canada – a...
- Feb 24, 2020
The Introduction of Alpha DaRT in Russia for Treatment of Metastatic Breast Cancer
On November 28, 2019, the first Alpha DaRT procedure was performed in Russia, at the A. Tsyb Medical Radiological Research Center in...
- Feb 16, 2020
How Israeli technology saved 78-year-old Leah from skin cancer
In August 2018, Jonathan and Na’ama Ellman, an Israeli couple living in the United States, brought their two-year-old son Ari to the...
- Feb 11, 2020
Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment
As the new Chief Medical Officer of Alpha Tau Medical, I passionately believe that the success of our new alpha-emitting radiation...
- Jan 27, 2020
Alpha DaRT treatment proves a success in first-in-human trial
Diffusing alpha-emitters radiation therapy (DaRT) uses interstitial radioactive seeds that continually release short-lived alpha-emitting...
- Dec 27, 2019
Israel's alpha radiation treatment shows tumor shrinkage in 100% of cases
Cancer is the second leading cause of death in the United States. Around the globe, cancer incidence has been steadily increasing over...
- Nov 26, 2019
Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra
Alpha DaRTâ„¢ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
bottom of page